The complexity of health insurance coverage rules, along with market trends that leave consumers open to more out-of-pocket costs, lead to mounting medical debt for consumers.
The saga of Martin Shkreli and Turing Pharmaceuticals focused a lot of attention on prescription drug prices, but no reversal of the exponential price increases for the lifesaving drug Daraprim resulted. The story offers an object lesson into the interworkings of the pharmaceutical market.
Surgeon General Jerome Adams urged more people to carry the drug naloxone, a lifesaving treatment for opioid overdoses. But this policy is tricky to implement.
The decision in Maryland’s case could slow momentum for other states that are attempting to take action to curb high drug costs.
President Trump, speaking Monday, called for a tough-on-crime federal approach. Meanwhile, on Capitol Hill, legislative strategies to combat this pressing public health problem are gaining momentum, but experts are not certain these approaches will make a difference.
How a prescription wiped out one woman’s health reimbursement account, raising questions about prescription drug price tags and about how health care professionals deal (or don’t) with medical costs.
Medicaid payments allow struggling hospitals to maintain vital costly services such as maternity care.
How physical and occupational therapists triumphed in a two-decade-long quest to overturn limits on their compensation.
Hospitals increasingly team up with lending institutions to offer low- or no-interest loans to patients to make sure their bills get paid. But critics say the complexity of hospital pricing means consumers should be cautious.
Algunos estados buscan impulsar al gobierno federal para que allane el camino para comprar stocks de medicamentos en Canadá con el fin de abaratar los costos y ahorrarle dinero a las arcas estatales.
Legislatures in blue and red states alike are considering proposals that would allow them to import prescription drugs from Canada.
The agreement would add $2 billion to the National Institutes of Health and fund community health centers around the country. But it does not include provisions to help stabilize the federal health law’s marketplaces.
With another piece of must-pass legislation set to move through Congress, there’s a push to attach provisions to keep afloat a number of health-related programs for which funding or specific federal direction has expired.
In Louisiana, the wining and dining of lawmakers by scores of pharma lobbyists proves a valuable lesson on how to win statehouse votes and influence profits.
It’s a regular part of the politically charged debate over health care. But the lines sometimes blur between rhetoric and how Canada’s system actually works.
El senador independiente por Vermont, Bernie Sanders, es un promotor de este sistema de pagador único, que ha desarrollado Canadá.
American single-payer advocates want to emulate Canada’s system. But many Canadian experts say the U.S. first needs to address some basic questions.
Based on research conducted at the University of Michigan’s medical center, a group of surgeons developed a strategy to help post-surgical patients from misusing or abusing their prescription painkillers.
The price for Pfizer’s Prevnar 13 has increased 5 to 6 percent each year since its 2010 approval by the Food and Drug Administration.
In an effort to reduce drug costs and increase efficiency, Massachusetts is seeking federal approval to implement a new approach to how the state’s Medicaid program covers prescription medications.